Pmv Pharmaceuticals Inc stock is traded at $1.26, with a volume of 194,299. It is down -1.18% in the last 24 hours and down -21.74% over the past month. PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
Previous Close:
$1.28
Open:
$1.28
24h Volume:
194,299
Relative Volume:
0.39
Market Cap:
$67.36M
Revenue:
-
Net Income/Loss:
-$78.34M
P/E Ratio:
-
EPS:
-$1.48
Net Cash Flow:
-$75.02M
1W Performance:
-3.82%
1M Performance:
-21.74%
6M Performance:
-13.10%
1Y Performance:
+0.80%
1-Day Range:
$1.24$1.29
1-Week Range:
$1.20$1.44
52-Week Range:
$1.02$1.91
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Name
Pmv Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
(609) 642-6670Address
400 ALEXANDER PARK DRIVE, PRINCETON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS